Tagworks Pharmaceuticals BV, a Netherlands-based pioneer in Click-to-Release chemistry that promotes more effective and safer systemic therapies, has secured $65 million in Series A funding. The investment round, which saw major participation from Spanish venture capital firm Ysios Capital and Gilde Healthcare, along with Novartis Venture Fund, New Enterprise Associates (NEA), and Lightstone Ventures, will […]
Aura Biosciences, a portfolio company of UK-based Arix Bioscience, has raised $80 million in a new funding round for developing virus-like drug conjugate (VDC) therapies for multiple oncology indications. The funding round of the US-based clinical-stage oncology company was led by Matrix Capital Management and Surveyor Capital, a Citadel company. New investors such as Rock […]
Galecto Biotech, a Denmark-based pharmaceutical company specializing in galectin modulators for severe diseases like idiopathic pulmonary fibrosis (IPF) and cancer, has successfully raised €79 million through a Series C financing round. This funding was co-led by Ysios Capital and OrbiMed. New and Existing Investors Support Galecto Biotech’s Growth The Series C round saw participation from […]